| Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging GW Albers, MP Marks, S Kemp, S Christensen, JP Tsai, ... New England Journal of Medicine 378 (8), 708-718, 2018 | 4371 | 2018 |
| Rivaroxaban for stroke prevention after embolic stroke of undetermined source RG Hart, M Sharma, H Mundl, SE Kasner, SI Bangdiwala, SD Berkowitz, ... New England Journal of Medicine 378 (23), 2191-2201, 2018 | 939 | 2018 |
| A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City JA Frontera, S Sabadia, R Lalchan, T Fang, B Flusty, P Millar-Vernetti, ... Neurology 96 (4), e575-e586, 2021 | 329 | 2021 |
| Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes M Mossa-Basha, WD Hwang, A De Havenon, D Hippe, N Balu, KJ Becker, ... Stroke 46 (6), 1567-1573, 2015 | 212 | 2015 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 183 | 2018 |
| Added value of vessel wall magnetic resonance imaging for differentiation of nonocclusive intracranial vasculopathies M Mossa-Basha, DK Shibata, DK Hallam, A De Havenon, DS Hippe, ... Stroke 48 (11), 3026-3033, 2017 | 102 | 2017 |
| Results from DEFUSE 3: good collaterals are associated with reduced ischemic core growth but not neurologic outcome A de Havenon, M Mlynash, MA Kim-Tenser, MG Lansberg, ... Stroke 50 (3), 632-638, 2019 | 100 | 2019 |
| Added value of vessel wall magnetic resonance imaging in the differentiation of moyamoya vasculopathies in a non-Asian cohort M Mossa-Basha, A de Havenon, KJ Becker, DK Hallam, MR Levitt, ... Stroke 47 (7), 1782-1788, 2016 | 96 | 2016 |
| Increased blood pressure variability after endovascular thrombectomy for acute stroke is associated with worse clinical outcome AE Bennett, MJ Wilder, JS McNally, JJ Wold, GJ Stoddard, JJ Majersik, ... Journal of NeuroInterventional Surgery 10 (9), 823-827, 2018 | 87 | 2018 |
| Blood pressure variability and neurologic outcome after endovascular thrombectomy: a secondary analysis of the BEST study EA Mistry, T Mehta, A Mistry, N Arora, AK Starosciak, ... Stroke 51 (2), 511-518, 2020 | 85 | 2020 |
| Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study S Yaghi, L Shu, E Bakradze, S Salehi Omran, JA Giles, JY Amar, ... Stroke 53 (3), 728-738, 2022 | 80 | 2022 |
| Posterior reversible encephalopathy syndrome with spinal cord involvement A de Havenon, Z Joos, L Longenecker, L Shah, S Ansari, K Digre Neurology 83 (22), 2002-2006, 2014 | 71 | 2014 |
| Association of collateral blood vessels detected by arterial spin labeling magnetic resonance imaging with neurological outcome after ischemic stroke A de Havenon, DR Haynor, DL Tirschwell, JJ Majersik, G Smith, W Cohen, ... JAMA neurology 74 (4), 453-458, 2017 | 68 | 2017 |
| Acute stroke care in a New York City comprehensive stroke center during the COVID-19 pandemic S Agarwal, E Scher, N Rossan-Raghunath, D Marolia, M Butnar, J Torres, ... Journal of Stroke and Cerebrovascular Diseases 29 (9), 105068, 2020 | 66 | 2020 |
| Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics A de Havenon, JJ Majersik, DL Tirschwell, JS McNally, G Stoddard, ... Neurology 92 (11), e1168-e1175, 2019 | 64 | 2019 |
| Anticoagulation use and hemorrhagic stroke in SARS-CoV-2 patients treated at a New York healthcare system A Kvernland, A Kumar, S Yaghi, E Raz, J Frontera, A Lewis, B Czeisler, ... Neurocritical Care 34, 748-759, 2021 | 62 | 2021 |
| Treatment with zinc is associated with reduced in-hospital mortality among COVID-19 patients: a multi-center cohort study JO Rahimian, S Yaghi, M Liu, A Lewis, A de Havenon, S Mainali, J Huang, ... Research square, 2020 | 61 | 2020 |
| The secret “spice”: an undetectable toxic cause of seizure A Havenon, B Chin, KC Thomas, P Afra The Neurohospitalist 1 (4), 182-186, 2011 | 60 | 2011 |
| High-resolution vessel wall MRI for the evaluation of intracranial atherosclerotic disease A De Havenon, M Mossa-Basha, L Shah, SE Kim, M Park, D Parker, ... Neuroradiology 59 (12), 1193-1202, 2017 | 58 | 2017 |
| Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke A de Havenon, A Bennett, GJ Stoddard, G Smith, L Chung, S O'Donnell, ... Stroke and Vascular Neurology 2 (1), 2017 | 57 | 2017 |
